Sirt7 Promotes Adipogenesis in the Mouse by Inhibiting Autocatalytic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin
ORIGINAL ARTICLE T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate Gluconeogenesis Atsushi Fukushima,1 Kim Loh,1 Sandra Galic,1 Barbara Fam,2 Ben Shields,1 Florian Wiede,1 Michel L. Tremblay,3 Matthew J. Watt,4 Sofianos Andrikopoulos,2 and Tony Tiganis1 OBJECTIVE—Insulin-induced phosphatidylinositol 3-kinase (PI3K)/Akt signaling and interleukin-6 (IL-6)-instigated JAK/ STAT3-signaling pathways in the liver inhibit the expression of ype 2 diabetes has reached epidemic propor- gluconeogenic genes to decrease hepatic glucose output. The tions, afflicting roughly 170 million people world- insulin receptor (IR) and JAK1 tyrosine kinases and STAT3 can wide. Although the underlying genetic causes serve as direct substrates for the T-cell protein tyrosine phos- Tand the associated pathologic symptoms are phatase (TCPTP). Homozygous TCPTP-deficiency results in peri- heterogenous, a common feature is high blood glucose due natal lethality prohibiting any informative assessment of to peripheral insulin resistance. Circulating insulin re- TCPTP’s role in glucose homeostasis. Here we have used leased from -cells in the pancreas serves to lower blood Ptpn2ϩ/Ϫ mice to investigate TCPTP’s function in glucose glucose by triggering the translocation of the facilitative homeostasis. GLUT4 to the plasma membrane in muscle and adipose RESEARCH DESIGN AND METHODS—We analyzed insulin tissue (1). Insulin also acts in the liver to promote glycogen sensitivity and gluconeogenesis in chow versus high-fat–fed synthesis and lipogenesis and to suppress hepatic glucose (HFF) Ptpn2ϩ/Ϫ and Ptpn2ϩ/ϩ mice and insulin and IL-6 production (HGP) by inhibiting gluconeogenesis and gly- signaling and gluconeogenic gene expression in Ptpn2ϩ/Ϫ and cogenolysis (1). -
The Controversial Role of Sirtuins in Tumorigenesis — SIRT7 Joins The
npg 10 Cell Research (2013) 23:10-12. npg © 2013 IBCB, SIBS, CAS All rights reserved 1001-0602/13 $ 32.00 RESEARCH HIGHLIGHT www.nature.com/cr The controversial role of Sirtuins in tumorigenesis – SIRT7 joins the debate Ling Li1, Ravi Bhatia1 1Division of Hematopoietic Stem cell and Leukemia Research, City of Hope National Medical Center, Duarte, CA 91010, USA Cell Research (2013) 23:10-12. doi:10.1038/cr.2012.112; published online 31 July 2012 Sirtuins are NAD-dependent function of SIRT7 is the least well un- first deacetylase with selectivity for the deacetylases that are conserved derstood so far. SIRT7 lacks conserved H3K18Ac modification. Low levels of from yeast to mammals. A new report amino acids within the catalytic domain H3K18Ac were previously shown to sheds light on the function of SIRT7, associated with deacetylase activity, and predict a higher risk of prostate cancer the least understood member of the although suggested to deacetylate the recurrence, and poor prognosis in lung, Sirtuin family by identifying its locus- tumor suppressor p53 (Figure 1) [3], has kidney and pancreatic cancers [8]. Us- specific H3K18 deacetylase activity, generally been considered to have weak ing chromatin immunoprecipitation and linking it to maintenance of cellu- or undetectable deacetylase activity [4, sequencing to study the genome-wide lar transformation in malignancies. 5]. There is evidence that SIRT7 can me- localization of SIRT7, Barber et al. Sirtuins are NAD-dependent deacety- diate protein interactions regulating the found that SIRT7 is enriched at promot- lases that have been linked to longev- RNA Pol I machinery [6]. -
A Review of the Recent Advances Made with SIRT6 and Its Implications on Aging Related Processes, Major Human Diseases, and Possible Therapeutic Targets
biomolecules Review A Review of the Recent Advances Made with SIRT6 and its Implications on Aging Related Processes, Major Human Diseases, and Possible Therapeutic Targets Rubayat Islam Khan †, Saif Shahriar Rahman Nirzhor † and Raushanara Akter * Department of Pharmacy, BRAC University, 1212 Dhaka, Bangladesh; [email protected] (R.I.K.); [email protected] (S.S.R.N.) * Correspondence: [email protected]; Tel.: +880-179-8321-273 † These authors contributed equally to this work. Received: 10 June 2018; Accepted: 26 June 2018; Published: 29 June 2018 Abstract: Sirtuin 6 (SIRT6) is a nicotinamide adenine dinucleotide+ (NAD+) dependent enzyme and stress response protein that has sparked the curiosity of many researchers in different branches of the biomedical sciences. A unique member of the known Sirtuin family, SIRT6 has several different functions in multiple different molecular pathways related to DNA repair, glycolysis, gluconeogenesis, tumorigenesis, neurodegeneration, cardiac hypertrophic responses, and more. Only in recent times, however, did the potential usefulness of SIRT6 come to light as we learned more about its biochemical activity, regulation, biological roles, and structure Frye (2000). Even until very recently, SIRT6 was known more for chromatin signaling but, being a nascent topic of study, more information has been ascertained and its potential involvement in major human diseases including diabetes, cancer, neurodegenerative diseases, and heart disease. It is pivotal to explore the mechanistic workings -
Targeting the Gastrointestinal Tract to Treat Type 2 Diabetes
230 3 P V BAUER and F A DUCA Gut treatment for diabetes 230:3 R95–R113 Review Targeting the gastrointestinal tract to treat type 2 diabetes Correspondence should be addressed 1,2 and 1 Paige V Bauer Frank A Duca to F A Duca 1Toronto General Hospital Research Institute and Department of Medicine, UHN, Toronto, ON, Canada Email 2Department of Physiology, University of Toronto, Toronto, ON, Canada frank.duca@uhnres. utoronto.ca Abstract The rising global rates of type 2 diabetes and obesity present a significant economic and Key Words social burden, underscoring the importance for effective and safe therapeutic options. f gut The success of glucagon-like-peptide-1 receptor agonists in the treatment of type 2 f metformin diabetes, along with the potent glucose-lowering effects of bariatric surgery, highlight f gut sensing the gastrointestinal tract as a potential target for diabetes treatment. Furthermore, f gut microbiota recent evidence suggests that the gut plays a prominent role in the ability of metformin f bile acids to lower glucose levels. As such, the current review highlights some of the current and potential pathways in the gut that could be targeted to improve glucose homeostasis, such as changes in nutrient sensing, gut peptides, gut microbiota and bile acids. Endocrinology A better understanding of these pathways will lay the groundwork for novel of gut-targeted antidiabetic therapies, some of which have already shown initial promise. Journal of Endocrinology (2016) 230, R95–R113 Journal Introduction The incidence of type 2 diabetes has more than doubled Interestingly, this is not the only evidence for a since 1980, with over 382 million affected individuals therapeutic role of the gut in diabetes treatment. -
The Sirtuin Family's Role in Aging and Age-Associated Pathologies
The sirtuin family’s role in aging and age-associated pathologies Jessica A. Hall, … , Yoonjin Lee, Pere Puigserver J Clin Invest. 2013;123(3):973-979. https://doi.org/10.1172/JCI64094. Review Series The 7 mammalian sirtuin proteins compose a protective cavalry of enzymes that can be invoked by cells to aid in the defense against a vast array of stressors. The pathologies associated with aging, such as metabolic syndrome, neurodegeneration, and cancer, are either caused by or exacerbated by a lifetime of chronic stress. As such, the activation of sirtuin proteins could provide a therapeutic approach to buffer against chronic stress and ameliorate age- related decline. Here we review experimental evidence both for and against this proposal, as well as the implications that isoform-specific sirtuin activation may have for healthy aging in humans. Find the latest version: https://jci.me/64094/pdf Review series The sirtuin family’s role in aging and age-associated pathologies Jessica A. Hall, John E. Dominy, Yoonjin Lee, and Pere Puigserver Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA. The 7 mammalian sirtuin proteins compose a protective cavalry of enzymes that can be invoked by cells to aid in the defense against a vast array of stressors. The pathologies associated with aging, such as metabolic syndrome, neuro- degeneration, and cancer, are either caused by or exacerbated by a lifetime of chronic stress. As such, the activation of sirtuin proteins could provide a therapeutic approach to buffer against chronic stress and ameliorate age-related decline. -
Granulosa-Lutein Cell Sirtuin Gene Expression Profiles Differ Between Normal Donors and Infertile Women
International Journal of Molecular Sciences Article Granulosa-Lutein Cell Sirtuin Gene Expression Profiles Differ between Normal Donors and Infertile Women Rebeca González-Fernández 1, Rita Martín-Ramírez 1, Deborah Rotoli 1,2, Jairo Hernández 3, Frederick Naftolin 4, Pablo Martín-Vasallo 1 , Angela Palumbo 3,4 and Julio Ávila 1,* 1 Laboratorio de Biología del Desarrollo, UD de Bioquímica y Biología Molecular and Centro de Investigaciones Biomédicas de Canarias (CIBICAN), Universidad de La Laguna, Av. Astrofísico Sánchez s/n, 38206 La Laguna, Tenerife, Spain; [email protected] (R.G.-F.); [email protected] (R.M.-R.); [email protected] (D.R.); [email protected] (P.M.-V.) 2 Institute of Endocrinology and Experimental Oncology (IEOS), CNR-National Research Council, 80131 Naples, Italy 3 Centro de Asistencia a la Reproducción Humana de Canarias, 38202 La Laguna, Tenerife, Spain; jairoh@fivap.com (J.H.); apalumbo@fivap.com (A.P.) 4 Department of Obstetrics and Gynecology, New York University, New York, NY 10016, USA; [email protected] * Correspondence: [email protected] Received: 13 November 2019; Accepted: 29 December 2019; Published: 31 December 2019 Abstract: Sirtuins are a family of deacetylases that modify structural proteins, metabolic enzymes, and histones to change cellular protein localization and function. In mammals, there are seven sirtuins involved in processes like oxidative stress or metabolic homeostasis associated with aging, degeneration or cancer. We studied gene expression of sirtuins by qRT-PCR in human mural granulosa-lutein cells (hGL) from IVF patients in different infertility diagnostic groups and in oocyte donors (OD; control group). Study 1: sirtuins genes’ expression levels and correlations with age and IVF parameters in women with no ovarian factor. -
Analysis of Sirtuin 1 Expression Reveals a Molecular Explanation of IL-2–Mediated Reversal of T-Cell Tolerance
Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2–mediated reversal of T-cell tolerance Beixue Gao, Qingfei Kong, Kyeorda Kemp, Yuan-Si Zhao, and Deyu Fang1 Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611 Edited by Arthur Weiss, University of California, San Francisco, CA, and approved December 8, 2011 (received for review November 9, 2011) The type III histone deacetylase sirtuin 1 (Sirt1) is a suppressor of both ably allowing accelerated T-cell proliferation and differentiation. innate and adoptive immune responses. We have recently found that Because Sirt1 is required for maintaining and IL-2 reverses T-cell Sirt1 expression is highly induced in anergic T cells. However, the peripheral tolerance, our findings here provide a possible explana- transcriptional program to regulate Sirt1 expression in T cells remains tion about the IL-2–mediated switch from anergy to activation. uncharacterized. Here we report that the early responsive genes 2 and 3, which can be up-regulated by T-cell receptor-mediated activa- Results tion of nuclear factor of activated T-cell transcription factors and are Differential Sirt1 Expression in Mouse Primary T Cells. We have re- involved in peripheral T-cell tolerance, bind to the sirt1 promoter to cently reported that sirt1 gene transcription is induced by TCR- transcript sirt1 mRNA. In addition, the forkhead transcription factor, mediated anergic signaling, and this increased Sirt1 expression is FoxO3a, interacts with early responsive genes 2/3 on the sirt1 pro- required to maintain peripheral T-cell tolerance (9). To further moter to synergistically regulate Sirt1 expression. -
Omega-3 Fatty Acids Upregulate SIRT1/3, Activate PGC-1Α Via Deacetylation, and Induce Nrf1 Production in 5/6 Nephrectomy Rat Model
marine drugs Article Omega-3 Fatty Acids Upregulate SIRT1/3, Activate PGC-1α via Deacetylation, and Induce Nrf1 Production in 5/6 Nephrectomy Rat Model Sung Hyun Son 1,† , Su Mi Lee 2,† , Mi Hwa Lee 3, Young Ki Son 2, Seong Eun Kim 2 and Won Suk An 2,* 1 Department of Internal Medicine, BHS Han Seo Hospital, Busan 48253, Korea; [email protected] 2 Department of Internal Medicine, Dong-A University, Busan 49201, Korea; [email protected] (S.M.L.); [email protected] (Y.K.S.); [email protected] (S.E.K.) 3 Department of Anatomy and Cell Biology, Dong-A University, Busan 49201, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-51-240-2811 † These authors contributed equally to this work. Abstract: Mitochondrial dysfunction contributes to the pathogenesis of kidney injury related with cardiovascular disease. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC- 1α) protects renal tubular cells by upregulating nuclear factor erythroid 2-related factor 2 (Nrf2). AMP- activated protein kinase (pAMPK)-mediated phosphorylation and sirtuin 1/3 (SIRT1/3)-mediated deacetylation are required for PGC-1α activation. In the present study, we aimed to investigate whether omega-3 fatty acids (FAs) regulate the expression of mediators of mitochondrial biogenesis in 5/6 nephrectomy (Nx) rats. Male Sprague-Dawley rats were assigned to the following groups: sham control, Nx, and Nx treated with omega-3 FA. The expression of PGC-1α, phosphorylated PGC- Citation: Son, S.H.; Lee, S.M.; Lee, 1α (pPGC-1α), acetylated PGC-1α, and factors related to mitochondrial biogenesis was examined M.H.; Son, Y.K.; Kim, S.E.; An, W.S. -
Sirtuin 7 Promotes Non‑Small Cell Lung Cancer Progression by Facilitating G1/S Phase and Epithelial‑Mesenchymal Transition and Activating AKT and ERK1/2 Signaling
ONCOLOGY REPORTS 44: 959-972, 2020 Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling YINGYING ZHAO1*, XIA YE1*, RUIFANG CHEN1, QIAN GAO1, DAGUO ZHAO2, CHUNHUA LING2, YULAN QIAN3, CHUN XU4, MIN TAO1 and YUFENG XIE1 Departments of 1Oncology, 2Respiratory Medicine, 3Pharmacy and 4Cardio-Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China Received November 26, 2019; Accepted May 29, 2020 DOI: 10.3892/or.2020.7672 Abstract. Increasing evidence has indicated the roles of (EMT) process of A549 NSCLC cells was facilitated by SIRT7 sirtuin 7 (SIRT7) in numerous human cancers. However, the overexpression, as evidenced by E-cadherin epithelial marker effects and the clinical significance of SIRT7 in human lung downregulation and mesenchymal markers (N-cadherin, cancer is largely unknown. The present research demonstrated vimentin, Snail and Slug) upregulation. In addition, SIRT7 that SIRT7 was increased in human lung cancer tumor tissues. knockdown in H292 NSCLC cells exhibited the opposite SIRT7 upregulation was associated with clinicopathological regulatory effects. Moreover, inhibition of AKT signaling characteristics of lung cancer malignancy including positive abated the promoting effects of SIRT7 in NSCLC cell prolif- lymph node metastasis, high pathologic stage and large tumor eration and EMT progression. The present data indicated that size. SIRT7 was also upregulated in human non-small cell lung SIRT7 accelerated human NSCLC cell growth and metastasis cancer (NSCLC) cell lines. Furthermore SIRT7-overexpressed possibly by promotion of G1 to S-phase transition and EMT A549 (A549-SIRT7) and SIRT7-knocked down H292 through modulation of the expression of G1-phase checkpoint (H292-shSIRT7) human NSCLC cell lines were established. -
The Soluble Adenylyl Cyclase Inhibitor LRE1 Prevents Hepatic Ischemia/Reperfusion Damage Through Improvement of Mitochondrial Function
International Journal of Molecular Sciences Article The Soluble Adenylyl Cyclase Inhibitor LRE1 Prevents Hepatic Ischemia/Reperfusion Damage Through Improvement of Mitochondrial Function João S. Teodoro 1,2,* , João A. Amorim 1,3,4 , Ivo F. Machado 1,2 , Ana C. Castela 1,2, Clemens Steegborn 5, David A. Sinclair 4,6, Anabela P. Rolo 1,2 and Carlos M. Palmeira 1,2,* 1 Center for Neurosciences and Cell Biology of the University of Coimbra, 3004-504 Coimbra, Portugal; [email protected] (J.A.A.); [email protected] (I.F.M.); [email protected] (A.C.C.); [email protected] (A.P.R.) 2 Department of Life Sciences of the University of Coimbra, 3000-456 Coimbra, Portugal 3 IIIUC—Institute of Interdisciplinary Research of the University of Coimbra, 3030-789 Coimbra, Portugal 4 Department of Genetics, Blavatnik Institute, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA 02115, USA; [email protected] 5 Department of Biochemistry, University of Bayreuth, 95440 Bayreuth, Germany; [email protected] 6 Laboratory for Ageing Research, Department of Pharmacology, School of Medical Sciences, The University of New South Wales, Sydney 2052, Australia * Correspondence: [email protected] (J.S.T.); [email protected] (C.M.P.); Tel.: +351-239-240-700 (J.S.T. & C.M.P.) Received: 13 May 2020; Accepted: 5 July 2020; Published: 11 July 2020 Abstract: Hepatic ischemia/reperfusion (I/R) injury is a leading cause of organ dysfunction and failure in numerous pathological and surgical settings. At the core of this issue lies mitochondrial dysfunction. -
Sirtuins Transduce Stacs Signals Through Steroid Hormone Receptors Henry K
www.nature.com/scientificreports OPEN Sirtuins transduce STACs signals through steroid hormone receptors Henry K. Bayele SIRT1 protects against several complex metabolic and ageing-related diseases (MARDs), and is therefore considered a polypill target to improve healthy ageing. Although dietary sirtuin- activating compounds (dSTACs) including resveratrol are promising drug candidates, their clinical application has been frustrated by an imprecise understanding of how their signals are transduced into increased healthspan. Recent work indicates that SIRT1 and orthologous sirtuins coactivate the oestrogen receptor/ER and the worm steroid receptor DAF-12. Here they are further shown to ligand-independently transduce dSTACs signals through these receptors. While some dSTACs elicit ER subtype-selectivity in the presence of hormone, most synergize with 17β-oestradiol and dafachronic acid respectively to increase ER and DAF-12 coactivation by the sirtuins. These data suggest that dSTACs functionally mimic gonadal steroid hormones, enabling sirtuins to transduce the cognate signals through a conserved endocrine pathway. Interestingly, resveratrol non-monotonically modulates sirtuin signalling, suggesting that it may induce hormesis, i.e. “less is more”. Together, the fndings suggest that dSTACs may be informational molecules that use exploitative mimicry to modulate sirtuin signalling through steroid receptors. Hence dSTACs’ intrinsic oestrogenicity may underlie their proven ability to impart the health benefts of oestradiol, and also provides a mechanistic insight into how they extend healthspan or protect against MARDs. Among the seven human sirtuins, SIRT1 (silent information regulator 2 homologue 1) has received the most attention because of its many roles including gene regulation, genomic stability and energy metabolism1,2. SIRT1 is also of enormous interest as a viable drug target because it protects against several conditions including obesity, type 2 diabetes, cancer and cardiovascular and neurodegenerative diseases3,4. -
Rapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1
Rapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1 Jorg van Loosdregt1,2, Diede Brunen1,3, Veerle Fleskens1,3, Cornelieke E. G. M. Pals1,3, Eric W. F. Lam4, Paul J. Coffer1,2,3* 1 Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands, 2 Center for Molecular & Cellular Intervention, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands, 3 Department of Cell Biology, University Medical Center Utrecht, Utrecht, The Netherlands, 4 CR-UK Labs and Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom Abstract Maintenance of Foxp3 protein expression in regulatory T cells (Treg) is crucial for a balanced immune response. We have previously demonstrated that Foxp3 protein stability can be regulated through acetylation, however the specific mechanisms underlying this observation remain unclear. Here we demonstrate that SIRT1 a member of the lysine deacetylase Sirtuin (SIRT) family, but not the related SIRTs 2–7, co-localize with Foxp3 in the nucleus. Ectopic expression of SIRT1, but not SIRTs 2–7 results in decreased Foxp3 acetylation, while conversely inhibition of endogenous SIRT activity increased Foxp3 acetylation. We show that SIRT1 inhibition decreases Foxp3 poly-ubiquitination, thereby increasing Foxp3 protein levels. Co-transfection of SIRT1 with Foxp3 results in increased Foxp3 proteasomal degradation, while SIRT inhibition increases FOXP3 transcriptional activity in human Treg. Taken together, these data support a central role for SIRT1 in the regulation of Foxp3 protein levels and thereby in regulation of Treg suppressive capacity. Pharmacological modulation of SIRT1 activity in Treg may therefore provide a novel therapeutic strategy for controlling immune responses.